Breaking News

Life Technologies Out-Licenses CHO Cell Lines

Life Technologies Corp. has finalized license agreements with several companies to provide rights to its CHO (Chinese hamster ovary) cell lines for the production of recombinant proteins used as therapeutic agents and vaccines.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Life Technologies Corp. has finalized license agreements with several companies to provide rights to its CHO (Chinese hamster ovary) cell lines for the production of recombinant proteins used as therapeutic agents and vaccines. The program is part of the company’s new out-licensing strategy, which also includes providing its product and technology portfolio to offer more customized solutions for OEM and other commercial use customers. New licensees include: Advanced BioScience Laboratories, I...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters